| CSL LTD |
| Australien |
| Gesundheit |
| AU000000CSL8 / 890952 |
| CSJ (Frankfurt) |
| FRA:CSJ, ETR:CSJ, CSJ:GR |
| - |
| https://www.csl.com/ |
|
CSL Limited is a leading Australian multinational biotechnology company specializing in the research, development, manufacturing, and marketing of lifesaving medicines and vaccines. The company’s portfolio includes plasma-derived therapies for cond..
>Volltext.. |
| 28425.81 Mio. EUR |
| 38467.59 Mio. EUR |
| 13553.12 Mio. EUR |
| 4398.66 Mio. EUR |
| 1247.89 Mio. EUR |
| 2.58 EUR |
| 9559.03 Mio. EUR |
| 982.68 Mio. EUR |
| - |
| 0.25 |
| -1.67% |
| -50.2% |
| 2.49 EUR |
| 4.41% |
| 4.4% |
| 10.03.26 - 1.1265442€ 09.09.25 - 1.3663388€ >weitere anzeigen... |
| - |
| CSL |
| 02.06.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|